Engage for What? Rethinking the Purpose of Stakeholder Engagement in Healthcare Research and Health Technology Assessment (HTA)

Author(s)

Discussion Leader: Anna Hyde, MA, Advocacy and Access, Arthritis Foundation, Silver Spring, MD, USA
Discussants: Jennifer Bright, MPA, Innovation and Value Initiative, Alexandria, VA, USA; Thomas W. Concannon, PhD, RAND Corporation, Boston, MA, USA; Ashley Valentine, MRes, Sick Cells, Washington, DC, USA

PURPOSE:

  • Identify gaps in existing stakeholder engagement efforts/models to inform healthcare research or HTA
  • Highlight the importance of using the ultimate goals to guide the process of engagement
  • Showcase some practical examples of how this might be done

DESCRIPTION:

There have been increasing efforts to apply a stakeholder engagement approach to elicit inputs from diverse stakeholders in healthcare research and HTA in recent years. As the HEOR community continues to broaden our outreach to different stakeholders and develop our toolkit in stakeholder engagement, it is important to review our existing models of stakeholder engagement and ensure that such approaches are designed to be fit for purpose.

In this workshop, Ms. Hyde will first discuss the importance of stakeholder engagement and introduce examples of existing models of stakeholder engagement (10 minutes). Ms. Valentine will share experiences and reflections from participating in stakeholder engagement efforts to inform healthcare research and HTA through the patient perspective (10 minutes). Dr. Concannon will then review the shortcomings of existing models for stakeholder engagement in HTA, and describe a fit-for-purpose approach to meaningful stakeholder engagement that can align engagement with research aims (15 minutes). Lastly, using IVI’s ongoing effort to develop an open-source economic model in major depressive disorder as an example, Ms. Bright will share key learnings on how meaningful stakeholder engagement might improve the relevance of economic models in HTA and illustrate how IVI plans to evaluate such impacts (15 minutes).

Insights from the workshop are applicable across all stakeholders: researchers will gain insights into designing and using an effective stakeholder engagement approach in applying methods to inform HTA; other stakeholders including patient groups, innovators, and payers will gain insights on collaborating with researchers in the engagement process to ensure that stakeholder feedback can lead to meaningful engagement that will ultimately benefit those that receive care.

Conference/Value in Health Info

2022-05, ISPOR 2022, Washington, DC, USA

Code

311

Topic

Health Technology Assessment

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×